Roxinova 150mg Tablet CR
Marketer
Innova Formulations Pvt Ltd
Salt Composition
Roxithromycin (150mg)
Overview Roxinova 150mg Tablet CR
Cefrox 150mg Extended-Release Tablets are a bacterial infection treatment. Effective against many infections affecting the respiratory system, ears, nose, throat, lungs, and skin, this antibiotic halts bacterial growth, alleviating symptoms. Administer orally on an empty stomach, following your physician's prescribed schedule with consistent intervals. Complete the entire course; premature cessation risks recurrence or exacerbation. Nausea, vomiting, abdominal discomfort, and diarrhea are potential, usually transient side effects. Persistent or severe side effects warrant medical attention. Prior to use, disclose any allergies or cardiac history to your doctor. Pregnant or lactating individuals must consult their physician before commencing treatment.
Uses of Roxinova 150mg Tablet CR
Managing bacterial infections
Major Benefits of Roxinova 150mg Tablet CR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Roxinova 150mg Controlled-Release Tablets should be administered on an empty stomach.
How to use Roxinova 150mg Tablet CR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Roxinova 150mg Tablet CR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Roxinova 150mg Tablet CR works:
Roxinova 150mg Controlled-Release tablets are a type of antibiotic medication. Their mechanism of action involves inhibiting the production of crucial bacterial proteins, thereby disrupting essential bacterial processes. This effectively halts bacterial proliferation and controls infection spread.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Roxinova 150mg Tablet CR and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The extended-release Roxinova 150mg tablet is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Extended-release Roxinova 150mg tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
Taking Roxinova 150mg CR tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if such effects are experienced.
KidneySAFE IF PRESCRIBED
For individuals with kidney disease, Roxinova 150mg CR tablets appear to pose minimal risk. Current evidence indicates dose modification may be unnecessary, but physician consultation is recommended.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Roxinova 150mg Controlled-Release tablets. Dosage modification of Roxinova 150mg CR may be necessary; physician consultation is recommended.
What if you forget to take Roxinova 150mg Tablet CR :
Should you forget to take a Roxinova 150mg CR tablet, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Roxinova 150mg Tablet CR
| Label | Value |
|---|---|
| Chemical Category | Modified macrolide antibiotic |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Behavioral Class | Macrolide antibiotics |
3,018 People bought this recently